Table 1.
Reference | No. of Patients | Cancer Type | Treatment | PRO-Related Conclusions |
---|---|---|---|---|
De Boer et al2 | 133 | H&N | Sx, RT | Factors predicting for better LRC and OS were high level of perceived self-efficacy, low score on uncertainty handling illness, more psychosocial complaints |
de Graeff et al3 | 208 | H&N | Sx, RT | Patients with cognitive score of 100 on EORTC QLQ-C30 had greater OS and LRC than those with a score of < 100 |
Fang et al4 | 102 | H&N | RT | High pretreatment baseline fatigue score predicted for significantly poorer 2-year OS. A 10-point increase in score resulted in 17% reduction in likelihood of survival |
Kaasa et al5 | 102 | NSCLC | CT, RT | General symptoms and psychosocial well being predicted for OS |
Langendijk et al6 | 198 | NSCLC | RT | Baseline global QOL scores significantly predicted for OS in patients with pathologically involved lymph nodes |
Montazeri et al7 | 129 | Lung | Pretreatment global QOL was a significant predictor of survival | |
Siddiqui et al8 | 1,093 | H&N | RT, RT + CT | FACT H&N and the functional well-being component of FACT-G predicted significantly for LRC |
Movsas et al9 | 239 | NSCLC | RT + CT | Baseline global QOL predicted for OS. A 10-point increase in baseline score decreased hazard of death by 10% |
Abbreviations: CT, chemotherapy; EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30; FACT-G, Functional Assessment of Cancer Therapy–General; FACT-H&N, FACT–Head and Neck; H&N, head and neck; LRC, locoregional control; NSCLC, non–small-cell lung cancer; OS, overall survival; QOL, quality of life; RT, radiation therapy; Sx, surgery.